BioCentury
ARTICLE | Clinical News

Enzo regulatory update

January 3, 1994 8:00 AM UTC

ENZ (Farmingdale, NY) received U.S. Patent No. 5,272,065, covering the regulation of gene activity using genetic antisense technology. The patent covers the use of nucleic acid constructs and the use ...